PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 2V7N

#CDRs = 8; #Clusters = 8.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	91.7	L1	12	L1-12-2	5	RASQSVSsNYLA	BBABBBBLLBBB
A	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	75.0	L2	8	L2-8-1	5	YDSSSRAT	BLLABBBB
A	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	0.0	L3	9	L3-9-2	22	HQYSDISPT	BBAABABBB
A	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	100.0	L4	6	L4-6-1	8	GSGTDF	EBEABB
B	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	69.2	H1	13	H1-13-1	7	AASGFTFRNSAMH	BBBLBBAAABBBB
B	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	70.0	H2	10	H2-10-*	-1	SIWYSGSNTY	BBBAALBBBB
B	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H3	12	H3-12-*	-1	ARFAGGWGAYDV	BBBAEAALEBAB
B	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H4	8	H4-8-1	7	RDNSKNTL	BBAAALBB
C	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	91.7	L1	12	L1-12-2	5	RASQSVSsNYLA	BBABBBBLLBBB
C	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	75.0	L2	8	L2-8-1	6	YDSSSRAT	BLLABBBB
C	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	0.0	L3	9	L3-9-2	22	HQYSDISPT	BBAABABBB
C	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	100.0	L4	6	L4-6-1	10	GSGTDF	EBEABB
D	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	69.2	H1	13	H1-13-1	7	AASGFTFRNSAMH	BBBLBBAAABBBB
D	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	70.0	H2	10	H2-10-*	-1	SIWYSGSNTY	BBBAALBLBB
D	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H3	12	H3-12-*	-1	ARFAGGWGAYDV	BBBAEAALEBAB
D	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H4	8	H4-8-1	7	RDNSKNTL	BBAAALBB
E	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	91.7	L1	12	L1-12-2	6	RASQSVSsNYLA	BBABBBBLLBBB
E	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	75.0	L2	8	L2-8-1	5	YDSSSRAT	BLLABBBB
E	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	0.0	L3	9	L3-9-2	24	HQYSDISPT	BBAABABBB
E	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	100.0	L4	6	L4-6-1	6	GSGTDF	EBEABB
F	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	69.2	H1	13	H1-13-1	7	AASGFTFRNSAMH	BBBLBBAAABBBB
F	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	70.0	H2	10	H2-10-*	-1	SIWYSGSNTY	BBBAALBLBB
F	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H3	12	H3-12-*	-1	ARFAGGWGAYDV	BBBAEAALEBAB
F	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H4	8	H4-8-1	7	RDNSKNTL	BBAAALBB
G	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	91.7	L1	12	L1-12-2	6	RASQSVSsNYLA	BBABBBBLLBBB
G	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	75.0	L2	8	L2-8-1	4	YDSSSRAT	BLLABBBB
G	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	0.0	L3	9	L3-9-2	20	HQYSDISPT	BBAABABBB
G	kappa	Synthetic.construct	Hu_IGKV3-20*02	95.7	Hu_IGKV3-20*02	100.0	L4	6	L4-6-1	9	GSGTDF	EBEABB
H	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	69.2	H1	13	H1-13-1	10	AASGFTFRNSAMH	BBBLBBAAABBBB
H	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	70.0	H2	10	H2-10-*	-1	SIWYSGSNTY	BBBAALBLBB
H	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H3	12	H3-12-*	-1	ARFAGGWGAYDV	BBBAEAALEBAB
H	heavy	Synthetic.construct	Hu_IGHV3-33*01	95.9	Hu_IGHV3-33*01	100.0	H4	8	H4-8-1	8	RDNSKNTL	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022